Creative Planning Fulgent Genetics, Inc. Transaction History

Creative Planning

$90.1 Billion
Q1 2024

A detailed history of Creative Planning transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Creative Planning holds 11,509 shares of FLGT stock, worth $229,949. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,509

Holding current value

$229,949

% of portfolio

0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$21.55 - $29.29 $248,018 - $337,098	11,509 New	11,509 $249,000
Q2 2023 Jul 21, 2023	SELL	$28.52 - $40.7 $29,318 - $41,839	-1,028 Reduced 13.22%	6,749 $249,000
Q1 2023 May 15, 2023	BUY	$29.39 - $36.27 $219,749 - $271,190	7,477 Added 2492.33%	7,777 $242,000
Q4 2022 Feb 10, 2023	BUY	$29.23 - $40.28 $8,769 - $12,084	300 New	300 $8,000
Q1 2022 May 16, 2022	SELL	$49.85 - $96.11 $168,293 - $324,467	-3,376 Closed	0 $0

Q4 2021 Feb 11, 2022	BUY	$77.3 - $105.0 $34,089 - $46,305	441 Added 15.03%	3,376 $340,000
Q3 2021 Nov 10, 2021	SELL	$74.87 - $110.87 $151,237 - $223,957	-2,020 Reduced 40.77%	2,935 $264,000
Q2 2021 Aug 04, 2021	SELL	$66.8 - $100.45 $2.1 Million - $3.16 Million	-31,411 Reduced 86.37%	4,955 $457,000
Q1 2021 Apr 30, 2021	BUY	$59.3 - $183.85 $1.03 Million - $3.21 Million	17,450 Added 92.25%	36,366 $3.51 Million
Q4 2020 Jan 29, 2021	BUY	$31.01 - $52.1 $586,585 - $985,523	18,916 New	18,916 $986,000

Others Institutions Holding FLGT

# of Institutions

199

Shares Held

14.7M

Call Options Held

1.16M

Put Options Held

92.9K

Black Rock Inc. New York, NY

3.92M
Shares

$78.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.42M
Shares

$28.5 Million
0.0% of portfolio
Dimensional Fund Advisors LP Austin, TX

1.35M
Shares

$26.9 Million
0.01% of portfolio
State Street Corp Boston, MA

824K
Shares

$16.5 Million
0.0% of portfolio
Park West Asset Management LLC Larkspur, CA

730K
Shares

$14.6 Million
1.15% of portfolio

View Full List

About Fulgent Genetics, Inc.

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $605M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

More about FLGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account